Atria Investments Inc Has $368,000 Stake in Doximity, Inc. (NASDAQ:DOCS)

Atria Investments Inc cut its stake in Doximity, Inc. (NASDAQ:DOCS) by 5.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,436 shares of the company’s stock after selling 489 shares during the period. Atria Investments Inc’s holdings in Doximity were worth $368,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. GAMMA Investing LLC boosted its stake in shares of Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares during the last quarter. Van ECK Associates Corp grew its stake in Doximity by 19.7% in the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock valued at $72,000 after purchasing an additional 427 shares in the last quarter. Cornercap Investment Counsel Inc. increased its position in Doximity by 3.2% during the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock worth $479,000 after buying an additional 537 shares during the last quarter. Farther Finance Advisors LLC raised its stake in Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the period. Finally, Arizona State Retirement System lifted its position in shares of Doximity by 2.4% in the second quarter. Arizona State Retirement System now owns 30,779 shares of the company’s stock valued at $861,000 after buying an additional 725 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

DOCS has been the subject of several research analyst reports. Bank of America lifted their target price on shares of Doximity from $32.00 to $45.00 and gave the stock a “neutral” rating in a report on Monday, October 7th. Wells Fargo & Company raised Doximity from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $19.00 to $41.00 in a report on Friday, November 8th. Baird R W raised Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Raymond James restated an “outperform” rating and issued a $65.00 price target (up from $37.00) on shares of Doximity in a research note on Friday, November 8th. Finally, Canaccord Genuity Group lowered shares of Doximity from a “buy” rating to a “hold” rating and increased their target price for the stock from $40.00 to $60.00 in a research report on Wednesday, November 13th. Eleven research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $52.27.

Doximity Stock Performance

Shares of NASDAQ:DOCS opened at $48.00 on Friday. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $61.75. The company has a market capitalization of $8.96 billion, a PE ratio of 55.17, a price-to-earnings-growth ratio of 4.18 and a beta of 1.30. The company has a fifty day moving average of $44.47 and a 200-day moving average of $34.84.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.